Stanford Health Care’s Janjri Desai, Pharm.D., says pharmacists improve outcomes but often can’t bill for it, making billing parity key to growing services.
|Articles|August 1, 2004
High costs ahead: Predictive modeling warns of upcoming trends
With the drug spend for Blue Cross and Blue Shield of Nebraska (BCBSNE) previously at less than 10% of total medical costs, the Omaha-based insurer didn't put too much energy into controlling costs. But when the 1990s started driving drug costs skyward-drug spend for the Blues plan is 15%, or $23 million per month today-BCBSNE looked for solutions to keep costs at bay.
Advertisement
Advertisement
Related to this article
Stanford Health Care’s Janjri Desai, Pharm.D., says pharmacy should be treated as a clinical service line, not just a 340B financial workhorse.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Medicaid can't opt out of gene therapies, so planning matters more, says Katelyn Meyer, Pharm.D. | AMCP Nexus 2026
2
How common is atopic dermatitis in the US? Not nearly as common as other research has shown, according to this study
3
5 things you should know about the midterms and healthcare
4
Lower fitness tied to persistent fatty liver disease in teen boys with obesity
5